http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2361168-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42bafb880871970d57dea45639fd1019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-32
filingDate 2000-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0aef02f86d9cc5b035cb970e0b5297b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e926d35f8ff513ca7474048ca08d019e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d84e0ebf07658d09cd3ac1f0c63ce72
publicationDate 2000-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2361168-A1
titleOfInvention Steroid sulfatase inhibitors and methods for making and using the same
abstract Novel sulfatase inhibitor compounds useful in the treatment of estrogen dependent illnesses are disclosed. These compounds generally comprise a steroid nucleus substituted at the C17 position. Methods for synthesizing these compounds and using them in the therapeutic and/or prophylactic treatment of a patient are also disclosed.
priorityDate 1999-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID509206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467410515
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID252737
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15589
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID828186
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50427
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100242994
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20905
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID412
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10029
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08842
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24800

Total number of triples: 43.